Abstract
This article focuses on the assessment of mechanistic relations with specific attention to medicine, where mechanistic models are widely employed. I first survey recent contributions in the philosophical literature on mechanistic causation, and then take issue with Federica Russo and Jon Williamson’s thesis that two types of evidence, probabilistic and mechanistic, are at stake in the health sciences. I argue instead that a distinction should be drawn between previously acquired knowledge of mechanisms and yet-to-be-discovered knowledge of mechanisms and that both probabilistic evidence and manipulation are essential with respect to newly discovered mechanisms.
Similar content being viewed by others
Notes
A world line is, in turn, defined as ‘the collection of points on a spacetime diagram that represents the history of an object. This means that processes are represented by elongated regions, or “worms” in spacetime’ [9, p. 90].
Machamer, Darden, Craver, and Glennan have been labeled as ‘neo-mechanists’; see Faucher [14].
See Campaner [15].
A different view is supported by Daniel Sirtes [16], who has been developing a ‘pragmatic-ontic account of mechanistic explanation’.
While criticizing the most recent revival of the mechanistic approach, and especially Machamer, Darden, and Craver’s notion of ‘activity’ as ‘far too opaque’, Schaffner admits that he has ‘frequently utilised references to “mechanisms” as another way to describe the “models” that are so widely found in biology, and which function broadly as surrogates for theories in the biomedical sciences’ [18, p. 398].
The role of interventions in the assessment of mechanistic relations has been discussed by Machamer, Darden, and Craver in various contributions; see, for instance, Darden and Craver [30], Machamer [31], Craver [32]. These scholars conceive of interventions mainly in a counterfactual sense. On this, see Campaner [33] and Campaner and Galavotti [34].
I thank Prof. Vineis for drawing my attention to this example. Mycotoxins are a broad class of toxic fungal metabolites estimated to contaminate up to 25% of the world’s food supplies. One potent group of mycotoxins are the aflatoxins, which are secondary metabolites of Aspergillus flavus (aflatoxins B1 and B2) and Aspergillus parasiticus (aflatoxins B1, B2, G1, and G2), aflatoxin B1 (AFB1) being the most common. They are present as mixtures in food (cereals, figs, oilseeds, nuts, tobacco, etc.), which work as substrates that allow for the growth and production of aflatoxin by aflatoxigenic moulds and are especially frequent in developing countries.
See, for instance, Strosnider et al. [35]; Williams et al. [36]; Wang and Tang [37]; Bennett and Klich [38]. Investigating the role that aflatoxins can play in the pathogenesis of hepatocellular carcinoma presents a number of difficulties. It is complicated to differentiate the influence of aflatoxins from that of HBV, to understand how representative the sampling of dietary components is at the population level, to estimate precisely human exposure, and, more generally, to collect data in the most affected countries (the poorest in the world). The use of animal models in studying aflatoxin carcinogenicity is controversial; see, for instance, Cardwell and Henry [39]; Montesano et al. [40]; Sylla et al. [41]; Turner et al. [42].
References
Sliwa, K., J. Fett, and U. Elkayan. 2006. Peripartum cardiomyopathy. Lancet 368: 687–693.
Whyte, M.P. 2006. Paget’s disease of bone. New England Journal of Medicine 355: 593–600.
Zhu, J.L., O. Basso, C. Obel, C. Bille, and J. Olsen. 2006. Infertility, infertility treatment, and congenital malformation: Danish national birth cohort. British Medical Journal 333: 679.
Stathis, P. 2002. Causation and mechanism. In Causation and explanation, 107–133. Durham, UK: Acumen Publishing Ltd.
Glennan, S. 2009. Mechanisms. In The oxford handbook of causation, ed. H. Beebee, C. Hitchcock, and P. Menzies, 315–325. Oxford: Oxford University Press.
Russo, F., and J. Williamson. 2007. Interpreting causality in the health sciences. International Studies in the Philosophy of Science 21: 157–170.
Salmon, W. 1984. Scientific explanation and the causal structure of the world. Princeton: Princeton University Press.
Salmon, W. 1998. Causality and explanation. Oxford: Oxford University Press.
Dowe, P. 2000. Physical causation. Cambridge: Cambridge University Press.
Machamer, P., L. Darden, and C. Craver. 2000. Thinking about mechanisms. Philosophy of Science 67: 1–25.
Glennan, S. 2002. Rethinking mechanistic explanation. Philosophy of Science 69: S342–S353.
Bechtel, W., and A. Abrahamsen. 2005. Explanation: A mechanist alternative. Studies in the History and Philosophy of the Biological and Biomedical Sciences 36: 421–441.
Vineis, P. 2000. Exposure, mutations and the history of causality. Journal of Epidemiology and Community Health 54: 652–653.
Faucher, L. 2006. What’s behind a smile? The return of mechanism: Reply to Schaffner. Synthese 151: 403–409.
Campaner, R. Forthcoming. Causality and explanation: Issues from epidemiology. In Explanation, prediction, and confirmation: New trends and old ones reconsidered, ed. S. Hartmann, M. Weber, W. J. Gonzalez, D. Dieks and T. Uebel. Dordrecht: Springer.
Sirtes, D. Working paper. A pragmatic-ontic account of mechanistic explanation. Phil-Sci Archive. http://philsci-archive.pitt.edu/5181/. Accessed Nov. 3, 2010.
Schaffner, K. Forthcoming. Theories, models, and equations in biology: The heuristic search for emergent simplifications in neurobiology. Phil-Sci Archive. http://philsci-archive.pitt.edu/3289/. Accessed Nov. 3, 2010.
Schaffner, K. 2006. Reduction: The Cheshire cat problem and a return to roots. Synthese 151: 377–402.
Vandenbroucke, J. 1998. Medical journals and the shaping of medical knowledge. Lancet 352: 2001–2006.
Vineis, P., and M. Porta. 1996. Causal thinking, biomarkers, and mechanisms of carcinogenesis. Journal of Clinical Epidemiology 49: 951–956.
Bell, J.I. 1999. Clinical research is dead; long live clinical research. Nature Medicine 5: 477–478.
Vineis, P., and M. Ghisleni. 2004. Risks, causality and the precautionary principle. Topoi 23: 203–210.
Wynder, E.L. 1994. Studies in mechanism and prevention: Striking a proper balance. American Journal of Epidemiology 139: 547–549.
Galavotti, M.C. 2008. Causal pluralism and context. In Reasoning, Rationality and Probability, ed. M.C. Galavotti, R. Scazzieri, and P. Suppes, 233–252. Stanford: CSLI.
Hitchcock, C. 1995. Discussion: Salmon on explanatory relevance. Philosophy of Science 62: 304–320.
Hitchcock, C. 1996. The mechanist and the snail. Philosophical Studies 84: 91–105.
Thagard, P. 1998. Explaining disease: Causes, correlations, and mechanisms. Minds and Machines 8: 61–78.
Thagard, P. 2007. Coherence, truth, and the development of scientific knowledge. Philosophy of Science 74: 28–47.
De Vreese, L. 2008. Causal (mis)understanding and the search for scientific explanations: A case study from the history of medicine. Studies in the History and Philosophy of the Biological and Biomedical Sciences 39: 14–24.
Darden, L., and C. Craver. 2002. Strategies in the interfield discovery of the mechanism of protein synthesis. Studies in the History and Philosophy of Biology and Biomedical Sciences 22: 1–28.
Machamer, P. 2004. Counterfactuals and causal explanation. International Studies in the Philosophy of Science 18: 41–72.
Craver, C. 2007. Explaining the brain. Oxford: Oxford University Press.
Campaner, R. 2006. Mechanisms and counterfactual: A different glimpse of the (secret?) connexion. Philosophica 77: 15–44.
Campaner, R., and M.C. Galavotti. 2010. Evidence and the assessment of causal relations in the health sciences. Paper presented at the Progress in Medicine Conference, University of Bristol, Bristol, U.K., April 13-15.
Thagard, P. 1998. Ulcers and bacteria I: Discovery and acceptance. Studies in History and Philosophy of Biological and Biomedical Sciences 29: 107–136.
Strosnider, A., E. Azziz-Baumgartner, M. Banziger, et al. 2006. Workgroup report: Public health strategies for reducing aflatoxin exposure in developing countries. Environmental Health Perspectives 114: 1898–1903.
Williams, J.H., T.D. Phillips, P.E. Jolly, J.K. Stiles, C.M. Jolly, and D. Aggarwal. 2004. Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences and interventions. American Journal of Clinical Nutrition 80: 1106–1122.
Wang, J., and L. Tang. 2005. Epidemiology of aflatoxin exposure and human liver cancer. In Aflatoxin and food safety, ed. H.K. Abbas, 195–211. Boca Raton, FL: CRC Press.
Bennett, W., and M. Klich. 2003. Mycotoxins. Clinical Microbiology Reviews 16: 497–516.
Cardwell, K.F., and S.H. Henry. 2005. Risk of exposure to and mitigation of effects of aflatoxin on human health: A West African example. In Aflatoxin and food safety, ed. H.K. Abbas, 213–235. Boca Raton, FL: CRC Press.
Montesano, R., P. Hainaut, and C.P. Wild. 1997. Hepatocellular carcinoma: From gene to public health. Journal of the National Cancer Institute 89: 1844–1851.
Sylla, A., M.S. Diallo, J. Castegnaro, and C.P. Wild. 1999. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: A molecular epidemiological approach. Mutation Research 428: 187–196.
Turner, P.C., A. Sylla, M.S. Diallo, J.J. Castegnaro, A.J. Hall, and C.P. Wild. 2002. The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conarky, West Africa. Journal of Gastroenterology and Hepatology 17: S441–S448.
McKillop, I.H., D.M. Moran, X. Jin, and L.G. Koniaris. 2006. Molecular pathogenesis of hepatocellular carcinoma. Journal of Surgical Research 136: 125–135.
Schaffner, K. 1993. Discovery and explanation in biology and medicine. Chicago: University of Chicago Press.
Hill, B. 1965. The environment of disease: Association or causation? Proceedings of the Royal Society of Medicine 58: 295–300.
Charlton, B.G. 1996. Attribution of causation in epidemiology: Chain or mosaic? Journal of Clinical Epidemiology 49: 105–107.
Weed, D. 1997. On the use of causal criteria. International Journal of Epidemiology 26: 1137–1141.
Wynder, E.L. 1996. Invited commentary: Response to Science article, ‘Epidemiology faces its limits’. American Journal of Epidemiology 143: 747–749.
Suriawinata, A., and X. Ruliang. 2004. An update on the molecular genetics of hepatocellular carcinoma. Seminars in Liver Disease 24: 77–88.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Campaner, R. Understanding mechanisms in the health sciences. Theor Med Bioeth 32, 5–17 (2011). https://doi.org/10.1007/s11017-010-9166-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11017-010-9166-5